Skip to main content
Clinical Trials/IRCT201201018574N1
IRCT201201018574N1CompletedPhase 2

Assessment of the effect of Albumin compared with Placebo on the reduction of the hematoma volume in patients with Hemorrhagic Stroke referred to Ahvaz Golestan Hospital

Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 149 years (—)
Sex
All

Inclusion Criteria

  • Inclusion Criteria : Primary Hemorrhagic Stroke; 24 hours from symptom onset; Above 18 years old.
  • Exclusion Criteria : Hematoma volume less than 7 ml; Need surgical evacuation; Pregnancy; Lactation; Systolic blood pressure less than 100 mmHg or more than 250 mmHg; Anticoagulant or Thrombolytic therapy; Serum Creatinine more than 2 mg/dl; History of known allergy to Albumin; History of severe allergic reactions known as latex gloves; Exacerbation of congestive heart failure within the past 6 months; Acute myocardial infarction in the last 6 months.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences

Similar Trials

Effect of Albumin on size of hematoma in... | Clinical Trial